Exposure to Subcutaneously Administered Butorphanol in Horses Pre‐Treated With Detomidine or Detomidine‐Vatinoxan
Open Access
- 31 January 2026
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (3) , 289-294
Abstract
The aim of the study was to determine the exposure to subcutaneously administered butorphanol in horses pre‐treated with intravenous (IV) detomidine, with or without vatinoxan, a peripherally selective alpha 2 ‐adrenoceptor antagonist. Five healthy, adult horses received three IV treatments 7 days apart, in a randomized, cross‐over design: detomidine 20 μg/kg (DET‐B), detomidine 20 μg/kg with vatinoxan 200 μg/kg (DETVAT‐B) and saline (S‐B), all followed by 0.1 mg/kg of butorphanol administered subcutaneously 30 min later. Venous samples were collected between 10 and 270 min after butorphanol administration. Butorphanol concentrations in plasma were analyzed with liquid chromatography coupled with triple quadruple mass spectrometry. Data were analyzed with non‐compartmental methods. The observed areas under plasma butorphanol concentration‐time curves were 8104 ± 2590, 7042 ± 2628 and 5996 ± 1670 ng·min/mL for DET‐B, DETVAT‐B and S‐B, respectively. There were no significant differences between treatments. Pre‐treatment with detomidine, with or without vatinoxan, did not significantly affect the exposure to subcutaneously administered butorphanol in this study.Keywords
Funding Information
- Eläinlääketieteen Tutkimuksen Tukisäätiö
- Vetcare
This publication has 23 references indexed in Scilit:
- The Impact of Vatinoxan on the Concentrations of Medetomidine, Midazolam, and Fentanyl in Central Nervous System After Subcutaneous Co‐Administration in RatsJournal of Veterinary Pharmacology and Therapeutics, 2025
- Pharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in male neutered catsVeterinary Anaesthesia and Analgesia, 2025
- The impact of vatinoxan on microcirculation after intramuscular co-administration with medetomidine in Beagle dogs: a blinded crossover studyVeterinary Anaesthesia and Analgesia, 2022
- Concentrations of vatinoxan and xylazine in plasma, cerebrospinal fluid and brain tissue following intravenous administration in sheepVeterinary Anaesthesia and Analgesia, 2021
- Effects of intramuscular vatinoxan (MK-467), co-administered with medetomidine and butorphanol, on cardiopulmonary and anaesthetic effects of intravenous ketamine in dogsVeterinary Anaesthesia and Analgesia, 2020
- The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horsesJournal of Veterinary Pharmacology and Therapeutics, 2020
- Concentrations of medetomidine enantiomers and vatinoxan, an α2-adrenoceptor antagonist, in plasma and central nervous tissue after intravenous coadministration in dogsVeterinary Anaesthesia and Analgesia, 2020
- Peripheral α2-adrenoceptor antagonism affects the absorption of intramuscularly coadministered drugsVeterinary Anaesthesia and Analgesia, 2018
- Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horsesJournal of Veterinary Pharmacology and Therapeutics, 2014
- A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.The Journal of Pharmacology and Experimental Therapeutics, 1988